Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report?

Core Viewpoint - Amedisys (AMED) shares have increased by approximately 1.3% since the last earnings report, outperforming the S&P 500, raising questions about the sustainability of this positive trend leading up to the next earnings release [1] Group 1: Earnings Report and Market Reaction - The most recent earnings report is crucial for understanding the catalysts affecting Amedisys [1] - Fresh estimates for Amedisys have remained flat over the past month, indicating a lack of significant changes in market expectations [2] Group 2: VGM Scores and Investment Strategy - Amedisys currently holds a Growth Score of A, but has a low Momentum Score of F, while receiving a B grade for value, placing it in the top 40% for this investment strategy [3] - The aggregate VGM Score for Amedisys is A, which is relevant for investors not focused on a single strategy [3] Group 3: Outlook - Amedisys has a Zacks Rank of 3 (Hold), suggesting an expectation of an in-line return from the stock in the upcoming months [4]